How many pills of Adagraxibu are in a box?

Adagrasib (Adagrasib) is indicated for people with KRAS determined by a test approved by the U.S. Food and Drug Administration (FDA) Treatment of adult patients with G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy (a treatment that is administered by injection or orally and affects the entire body).

For oral use, adagrasib tablets contain 200mg The marketed specifications of adagrasib are 200mg*180 tablets per box, oval, white to off-white, immediate-release film-coated tablets, marked with "200" on one side and "M" on the other side. Packaged in white opaque square high-density polyethylene bottles with desiccant and polypropylene and typically stored at room temperature 20°C to 25°C (68°F to 77°F).

Adagrasib is an irreversible inhibitor of KRAS G12C, which belongs to the RAS GTPase family. Genetic changes in the KRAS gene produce an altered protein that leads to uncontrolled growth of cancer cells. The active substance in adagrasib attaches to this altered protein in cancer cells, rendering the protein inactive and slowing the growth and spread of the cells. It also promotes the process of killing cancer cells.

Sinceadagrasibthe original drug has not yet been launched in China, patients can only purchase adagrasib through overseas channels, and the U.S. original version of 200mg*180 tablets is priced at hundreds of thousands of yuan per box (the price may fluctuate due to exchange rates), which is very expensive. Currently, there are no generic drugs of adagrasib produced overseas. For more drug information and specific prices, please consult Yaode’s medical consultant.